Cannabidiol

Potential Contaminants in CBD and THC Oils

Cannabidiol (CBD) was initially discovered as a medication to treat Dravet syndrome, but is now used extensively to treat several medical and lifestyle disorders in addition to being used as recreational drug.

Can CBD Oil Be Used to Treat Epilepsy?

Does CBD Oil Work for Arthritis Pain?

Differences Between Cannabidiol (CBD) and Tetrahydrocannabinol (THC)

Can CBD be Used to Treat Drug Addiction?

Can CBD be Used to Prevent or Treat Psychosis?

Obesity Prevalence Among Cannabis Users

Does Diet Affect CBD Absorption?

Latest Cannabidiol News and Research

Novel cannabis plant extracts could protect against COVID-19

Researchers in Canada have conducted a study suggesting that novel Cannabis sativa extracts may decrease levels of the host cell receptor that severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) uses to gain viral entry to target tissues.

26 Nov 2020

Cannabidiol oils are equally or less effective at inhibiting certain cancer cell lines

Cannabidiol (CBD) oils are equally or less effective at inhibiting the growth of certain cancer cells compared to pure CBD, according to Penn State College of Medicine researchers.

18 Nov 2020

Study: Cannabidiol molecule contains more potent antioxidants

Nowadays, cannabidiol is a star component, not only in the world of cosmetics, but also in pharmaceutics and nutrition due to its antioxidant properties and its therapeutical potential.

17 Nov 2020

USask researchers to study how cannabis use during pregnancy affects fetus' brain development

University of Saskatchewan pharmacologist Robert Laprairie will use a Brain Canada research grant to determine how a mother's use of cannabis during pregnancy affects the brain of the developing fetus she's carrying.

9 Nov 2020

Study finds higher cannabis dose is associated with larger reductions in OCD compulsions

People with obsessive-compulsive disorder, or OCD, report that the severity of their symptoms was reduced by about half within four hours of smoking cannabis, according to a Washington State University study.

20 Oct 2020

SGD Pharma introduces Ensiemo, the new complete child-resistant packaging solution for CBD oils

SGD Pharma today announces the launch of its new full packaging solution dedicated to the cannabidiol (CBD) oil market.

23 Sep 2020

Pharmaceutical researchers aim to create better CBD-like treatments

Cannabidiol (CBD) is an increasingly popular wellness trend. The compound, which occurs naturally in cannabis plants, is added to many products that claim to reduce anxiety, alleviate pain and more, without the intoxication of its cousin tetrahydrocannabinol (THC).

2 Sep 2020

Study reveals how a cannabinoid may treat acute respiratory distress syndrome

Acute Respiratory Distress Syndrome, when caused by a bacterial toxin known as Staphylococcal enterotoxin, can be completely prevented by treatment with Δ9-tetrahydrocannabinol (THC), a cannabinoid found in the cannabis plant.

26 Aug 2020

Will smoking cannabis harm your heart?, yes says AMA

The American Heart Association (AHA), in their statement, has said that smoking cannabis (marijuana) could be harmful to the heart. This new stand on smoking weed was published this week in the journal Circulation. The announcement is released as an article titled, “Medical Marijuana, Recreational Cannabis, and Cardiovascular Health: A Scientific Statement From the American Heart Association.”

6 Aug 2020

Cannabinoids may alter the effects of some prescription drugs

Cannabinoid-containing products may alter the effects of some prescription drugs, according to Penn State College of Medicine researchers.

3 Aug 2020

FDA approves CBD oral solution for treatment of seizures related to tuberous sclerosis complex

Today, the U.S. Food and Drug Administration approved Epidiolex (cannabidiol) [CBD] oral solution for the treatment of seizures associated with tuberous sclerosis complex (TSC) in patients one year of age and older.

31 Jul 2020

New program can help laboratories measure key chemical compounds in cannabis products

The National Institute of Standards and Technology (NIST) has launched a program to help laboratories accurately measure key chemical compounds in marijuana, hemp and other cannabis products including oils, edibles, tinctures and balms.

28 Jul 2020

CBD may help reduce cytokine storm and excessive lung inflammation in COVID-19

Cannabidiol, or CBD, may help reduce the cytokine storm and excessive lung inflammation that is killing many patients with COVID-19, researchers say.

16 Jul 2020

UHN leads first-of-its-kind real world evidence study of medical cannabis

Medical cannabis is finally being put under the microscope, in a first-of-its-kind real world evidence study led by Dr. Hance Clarke, Director of Pain Services, Toronto General Hospital, and a recognized leader in educating Canadians about chronic pain management and the risk factors of continued opioid use.

9 Jul 2020

Cannabidiol may reduce behavioral problems in children with intellectual disabilities

Cannabidiol, a type of medicinal cannabis, may reduce severe behavioral problems in children and adolescents with an intellectual disability a new study has found.

24 Jun 2020

Determining Cannabinoids in Marijuana-Infused Edibles

Marijuana-infused edibles or medibles have increased immensely over the last 10 years. With products such as brownies and gummy bears infused with marijuana, it is more important now than ever to test these cannabis-related products.

From Pittcon 12 Jun 2020

Cannabis temporarily reduces severity of PTSD symptoms

People suffering from post-traumatic distress disorder report that cannabis reduces the severity of their symptoms by more than half, at least in the short term, according to a recent study led by Carrie Cuttler, a Washington State University assistant professor of psychology.

9 Jun 2020

GMU researchers studying effect of cannabidiol on exosome release

Fatah Kashanchi, Professor, Laboratory of Molecular Virology, School of Systems Biology, and Lance Liotta, Co-Director, Applied Proteomics and Molecular Medicine, are working to mitigate virally driven HIV pathenogenesis in the central nervous system.

5 Jun 2020

Researchers assess harm reduction awareness among frequent cannabis users

Harm reduction strategies have proven effective for use of opioids, alcohol, and tobacco products.

30 May 2020

CBD treatment improves arthritis symptoms in dogs, study finds

A team led by researchers at Baylor College of Medicine in collaboration with Medterra CBD conducted the first scientific studies to assess the potential therapeutic effects of cannabidiol for arthritic pain in dogs, and the results could lead the way to studying its effect in humans.

28 May 2020